| GC46808-10mg |
|
2414916-45-1 |
|
0 |
C22H18Cl2N4O2S2 |
|
|
|
| GC46808-5mg |
|
2414916-45-1 |
|
0 |
C22H18Cl2N4O2S2 |
|
|
|
| GC46808-1mg |
|
2414916-45-1 |
|
0 |
C22H18Cl2N4O2S2 |
|
|
|
| GC46807-1mg |
|
— |
Adrenomedullin (1-52) (porcine) (trifluoroacetate salt)
|
0 |
C262H403N79O76S3.XCF3COOH |
|
|
|
| GC46806-10g |
|
— |
Adenosine 5’-diphosphate (potassium salt hydrate)
|
0 |
C10H15N5O10P2.K [XH2O] |
|
|
|
| GC46806-5g |
|
— |
Adenosine 5’-diphosphate (potassium salt hydrate)
|
0 |
C10H15N5O10P2.K [XH2O] |
|
|
|
| GC46806-1g |
|
— |
Adenosine 5’-diphosphate (potassium salt hydrate)
|
0 |
C10H15N5O10P2.K [XH2O] |
|
|
|
| GC46805 |
|
1190021-70-5 |
|
0 |
C8H8D4N5O4P |
|
|
|
| GC46804-1mg |
|
— |
|
0 |
C19H19D9N4O2 |
|
|
|
| GC46804-500μg |
|
— |
|
0 |
C19H19D9N4O2 |
|
|
|
| GC46802-1mg |
|
— |
|
0 |
C20H20D9N3O2 |
|
|
|
| GC46802-500μg |
|
— |
|
0 |
C20H20D9N3O2 |
|
|
|
| GC46799-5mg |
|
— |
ADB-BUTINACA N-(4-hydroxybutyl) metabolite
|
0 |
C18H26N4O3 |
|
|
|
| GC46799-1mg |
|
— |
ADB-BUTINACA N-(4-hydroxybutyl) metabolite
|
0 |
C18H26N4O3 |
|
|
|
| GC46798-1mg |
|
1276433-89-6 |
|
0 |
C28H25D3O3 |
|
|
|
| GC46798-500μg |
|
1276433-89-6 |
|
0 |
C28H25D3O3 |
|
|
|
| GC46797-1mg |
|
1185179-33-2 |
|
0 |
C8H7D4N5O3 |
|
|
|
| GC46796-10mg |
|
— |
Ac-WEHD-AFC (trifluoroacetate salt)
|
0 |
C38H37F3N8O11.XCF3COOH |
|
|
|
| GC46796-5mg |
|
— |
Ac-WEHD-AFC (trifluoroacetate salt)
|
0 |
C38H37F3N8O11.XCF3COOH |
|
|
|
| GC46796-1mg |
|
— |
Ac-WEHD-AFC (trifluoroacetate salt)
|
0 |
C38H37F3N8O11.XCF3COOH |
|
|
|
